KUKJEON PHARMACEUTICAL Co., Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.00003 million compared to sales of KRW 0.00049 million a year ago. Net income was KRW 8,947.84 million compared to KRW 4,038.01 million a year ago.

Basic earnings per share from continuing operations was KRW 182 compared to KRW 91 a year ago. Diluted earnings per share from continuing operations was KRW 11 compared to KRW 91 a year ago. Basic earnings per share was KRW 182 compared to KRW 91 a year ago.

Diluted earnings per share was KRW 11.